ALPHAMEDIX LIMITEDActive

Company number 09823544Private limited companyIncorporated 2015

Key figures

£22,370+27.8%
Net assets 2024/25
+44.9%
Average annual growth 2019/20–2024/25
010 k20 k30 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ALPHAMEDIX LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets14,84131,71527,96034,60833,049
Total liabilities10,70922,27813,99217,10410,679
Net assets / total equity4,1329,43713,96817,50422,370
Average number of employees33444

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ALPHAMEDIX LIMITED

Company

ALPHAMEDIX LIMITED is a private limited company registered with Companies House under company number 09823544. It was incorporated on 14 Oct 2015. Its status is active. The registered office is in Bolton (BL6). Its nature of business (SIC 2007) is buying and selling of own real estate (68100), renting and operating of Housing Association real estate (68201), other letting and operating of own or leased real estate (68209), management of real estate on a fee or contract basis (68320).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were £22,370, up 27.8% on the previous year. Total assets were £33,049 and total liabilities £10,679. The company had an average of 4 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 22 Dec 2026.